Ken Fisher and 14 Other Big Funds Sold Lumentum Last Quarter, While 18 Bought. Who’s Right?

Roxanna Maglangit • 6 minute read
Reviewed by: Michael Douglass
Last updated Nov 19, 2026

@da-kuk from Getty Images Signature via Canva

Key Takeaways

  • Of the 460 big funds that have filed 13Fs for the quarter ended Sept. 30, 18 bought Lumentum and 15 sold it. Ken Fisher’s Fisher Investments was one of the sellers.
  • Lumentum is 43% below its Sept. 30 price, and Marvell’s all-stock offer now ties its price to Marvell’s shares until the deal closes or breaks.
  • In the same quarter, two of the sellers, Fisher Investments and Axiom Investors, added to Cisco, which trades at about 17x forward earnings.
  • The buyers have the better case from here: analysts have raised their Lumentum earnings estimates, and its forward P/E of about 19x sits well below its five-year average of 30x.

The big funds split almost down the middle on Lumentum (LITE) last quarter, and so far, the sellers look smarter.

Of the 460 big funds that have filed 13Fs for the quarter ended Sept. 30 (a fund with a famous name, or $1 billion or more of US stocks in its 13F, with quant and index funds left out), 18 bought Lumentum and 15 sold it. Another 37 held it at the quarter’s end. Since then, the stock has fallen 43%, and on Nov. 2, Marvell Technology (MRVL) agreed to buy Lumentum with its own stock.

Ken Fisher’s sale was small change

Fisher Investments, which manages $387 billion, cut its Lumentum stake 99% in the third quarter, to 306 shares from 42,151, its 13F for the quarter ended Sept. 30, filed Nov. 6, shows. That’s about $41 million of stock at quarter-end prices, a sliver of the $348 billion of US stocks in its 13F. The biggest sales came from funds where Lumentum was a big position. The $7.2 billion Evergreen Quality Fund (that’s what its 13F holds in US stocks) sold all 399,855 of its shares, a stake worth $343 million and 5.5% of its 13F stocks at the end of June. The $3.8 billion Avala Global sold out of a stake that had been 5.8% of its own. And the $28 billion Axiom Investors cut its holding 41%, to 240,706 shares worth $234 million, though Lumentum was still its 16th-largest position, at 1.7% of its 13F stocks.

TIKR tracks 25 analysts on Lumentum. How many say “Buy”?

See the full breakdown of Buy, Hold, and Sell ratings on Lumentum, along with Wall Street’s revenue and earnings estimates, all in one place. More than 500,000 investors use TIKR to research stocks like this one. See Lumentum’s Analyst Ratings

Viking and Maverick bought in size

The $12 billion Castle Hook Partners made the biggest buy, taking its stake to 175,607 shares from 3,004. That added about $168 million of stock at quarter-end prices. Andreas Halvorsen’s Viking Global, which manages $78 billion, opened a new position of 153,510 shares worth $149 million, and Lee Ainslie’s $16 billion Maverick Capital went to 148,753 shares from 1,032. That made Lumentum 1.4% of Castle Hook’s 13F stocks and 1.2% of Maverick’s. In the same quarter, eight of the 15 sellers added to Meta Platforms, and six of the 18 buyers sold or cut Snowflake.

Marvell now sets the price

On Nov. 2, Marvell agreed to pay 4.5 of its own shares for each Lumentum share, a deal it valued at about $1,132 a Lumentum share. Marvell’s stock has slid since, and Lumentum’s offer has shrunk with it. At $551, Lumentum trades as if Marvell were worth about $122 a share, so anyone buying Lumentum today is mostly betting on Marvell’s stock and on the deal closing. The companies are aiming to close in the first half of 2028, and analysts expect China’s antitrust review to take 12 to 18 months. If regulators block the deal, Marvell owes Lumentum $3.2 billion, roughly $35 a share.

The numbers back the buyers

If the deal broke, holders would keep a business whose earnings estimates are climbing. Analysts expect its normalized EPS to nearly triple, from $8.67 in fiscal 2026 to $24.94 in fiscal 2027 (the year to June 2027), and reach $40.13 a year later:

Bar chart from TIKR of Lumentum's normalized EPS, actual and consensus estimates, $ per share, fiscal 2023-2028 (years to June).
Lumentum (LITE): normalized EPS, actual and consensus estimates, $ per share, fiscal 2023-2028 (years to June) (TIKR)

Those estimates stood at $21.79 and $35.92 in late October, so they’ve gone up as the stock has gone down. And the stock trades at about 19x forward earnings, well below its five-year average of 30x:

Line chart from TIKR of Lumentum's forward (NTM) P/E, last 5 years.
Lumentum (LITE): forward (NTM) P/E, last 5 years (TIKR)

Analysts’ targets mean less while the deal is pending: Bernstein cut its target to $635 from $900 on Nov. 9, then raised it to $700 a day later to track Marvell’s price.

Cisco is the steadier ride

Two of the sellers went the other way on Cisco (CSCO) in the same quarter. Fisher added 22%, to 40.65 million shares worth $4.37 billion, 1.3% of its 13F stocks, and Axiom added 66%, to 1.08 million shares worth $117 million. Cisco is down just 10% from its Sept. 30 price, though it slipped after it raised its earnings outlook last week. At about 17x forward earnings, it’s only a little cheaper than Lumentum, whose earnings analysts expect to nearly triple this fiscal year.

I’d side with the buyers

The sellers have been right on price since Sept. 30, but at $551, the buyers have the better case. A Lumentum share today gets you rising earnings estimates at a multiple well below the stock’s own history, 4.5 Marvell shares if the deal closes, and a $3.2 billion fee for Lumentum if regulators block it. The risk is that Lumentum now trades with Marvell and the AI hardware group, which slid again on Nov. 16 on leadership turmoil at Nvidia.

Marvell reports on Dec. 1, and since its stock sets Lumentum’s price, that’s the first test. Lumentum’s December-quarter report, expected in February, then needs to keep fiscal 2027 estimates near $24.94 a share for the standalone case to hold.

So what is Lumentum stock actually worth if the deal doesn’t go through?

TIKR lets you forecast the future price of any stock in less than a minute. Just enter a few assumptions into TIKR’s valuation model and see what Lumentum could be worth. Start from Wall Street consensus estimates, or adjust the inputs to reflect your own view of the business. It’s free to use.

Value Lumentum for free

Disclaimer:

Please note that the articles on TIKR are not intended to serve as investment or financial advice from TIKR or our content team, nor are they recommendations to buy or sell any stocks. We create our content based on TIKR Terminal’s investment data and analysts’ estimates. Our analysis might not include recent company news or important updates. TIKR has no position in any of the stocks mentioned. Thank you for reading, and happy investing!

Join thousands of investors worldwide who use TIKR to supercharge their investment analysis.

Sign Up for FREENo credit card required